Caris Nanoverse
Exploring the Biological Nanoverse to Better Detect, Categorize and Inform Healthcare
Through the power of AI and vast amounts of molecular data, Caris has developed a revolutionary mechanism to unravel the biological complexity of diseases. The Caris Nanoverse™ provides physicians and researchers a new way to identify patient populations, predict therapy responses and identify targets for drug development in ways never before possible.
Driving Molecular Science Innovation
748,000+
Cases
6.5+ Million
Tests
38+ Billion
Molecular Markers Measured
Discover
More
Caris Life Sciences contributes to the body of research in oncology to advance the understanding of molecular science and further enable the delivery of precision medicine.
Caris is actively delivering on the promise of precision medicine and our pipeline reflects our future tests and molecular science-based solutions to help patients and improve the human condition.
Have questions?
"*" indicates required fields